News

  • 17 August 2018

    EpiPen generic version by Teva secures FDA approval

    The US Food and Drug Administration (FDA) has approved the first generic version of the EpiPen to treat allergic reactions in emergency cases, including life-threatening (anaphylaxis) conditions.

  • 16 August 2018

    Wearable device can measure electrophysiological signals

    A research team at the Center for Nanoparticle Research, within the Institute for Basic Science (IBS), has developed a wearable and implantable device that measures electrophysiological signals and applies electrical...